1889-836x

Revista de Osteoporosis y Metabolismo Mineral

ARAN Ediciones

View prefix report (10.20960)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 82 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact82 DOIs
2

Attach ORCID iDs across 82 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact82 DOIs
3

Add license metadata to 82 records

License metadata tells indexers and readers how each article may be reused.

High impact82 DOIs

DOIs for this ISSN

Showing the top 5 of 82 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Calcinosis cutis (10.20960/revosteoporosmetabminer.00025)
Abstract ORCID License
35.78 2
2 High and extremely high risk of osteoporotic fractures in Ch… (10.20960/revosteoporosmetabminer.00001)
Abstract ORCID License
22.58 1
3 Osteoclast generation from RAW 264.7 and PBMC cells. The set… (10.20960/revosteoporosmetabminer.00005)
Abstract ORCID License
22.58 1
4 Adherence to denosumab during the COVID-19 pandemic (10.20960/revosteoporosmetabminer.00045)
Abstract ORCID License
22.58 1
5 Alteration of bone quality and prevalence of fragility fract… (10.20960/revosteoporosmetabminer.00054)
Abstract ORCID License
22.58 1
6 Advances in regenerative medicine for orthopedic disorders:… (10.20960/revosteoporosmetabminer.00078)
Abstract ORCID License
22.58 1
7 The role of parathyroid hormone related protein (PTHrP) in b… (10.20960/revosteoporosmetabminer.00004)
Abstract ORCID License
0.00 0
8 Implication of connexins, integrins and primary cilium in bo… (10.20960/revosteoporosmetabminer.00006)
Abstract ORCID License
0.00 0
9 The secretome of mechanically stimulated osteocytes modulate… (10.20960/revosteoporosmetabminer.00007)
Abstract ORCID License
0.00 0
10 Genome-wide association studies (GWAS) vs functional validat… (10.20960/revosteoporosmetabminer.00008)
Abstract ORCID License
0.00 0
11 Saber tibia (10.20960/revosteoporosmetabminer.00009)
Abstract References ORCID License
0.00 0
12 Analysis of drug holiday or therapeutic breaks regarding tre… (10.20960/revosteoporosmetabminer.00010)
Abstract ORCID License
0.00 0
13 Romosozumab: confusion regarding its indications (10.20960/revosteoporosmetabminer.00011)
Abstract ORCID License
0.00 0
14 Effect of extracellular vesicles derived from hypoxia-precon… (10.20960/revosteoporosmetabminer.00012)
Abstract ORCID License
0.00 0
15 Cellular senescence as a pathogenic factor and potential the… (10.20960/revosteoporosmetabminer.00013)
Abstract ORCID License
0.00 0
16 Polygenic risk of bone fractures in Spanish women with osteo… (10.20960/revosteoporosmetabminer.00014)
Abstract ORCID License
0.00 0
17 Refinement of the osteoporotic fracture risk categorization (10.20960/revosteoporosmetabminer.00015)
Abstract ORCID License
0.00 0
18 Heterotopic ossification after hip arthroplasty: role of bon… (10.20960/revosteoporosmetabminer.00016)
Abstract ORCID License
0.00 0
19 Follow-up and compliance to anti-osteoporotic treatment from… (10.20960/revosteoporosmetabminer.00017)
Abstract ORCID License
0.00 0
20 Impact of fragility fractures in postmenopausal Spanish wome… (10.20960/revosteoporosmetabminer.00018)
Abstract ORCID License
0.00 0
21 Association of gamma glutamyl transferase in the presence an… (10.20960/revosteoporosmetabminer.00019)
Abstract ORCID License
0.00 0
22 Should the FRAX tool include other variables to assess fragi… (10.20960/revosteoporosmetabminer.00020)
Abstract ORCID License
0.00 0
23 Efficacy of an oral collagen therapy compared with intra-art… (10.20960/revosteoporosmetabminer.00021)
Abstract ORCID License
0.00 0
24 Postmenopausal osteoporosis with vertebral fracture: teripar… (10.20960/revosteoporosmetabminer.00022)
Abstract References ORCID License
0.00 0
25 Role of sex hormones in bone homeostasis and their role in t… (10.20960/revosteoporosmetabminer.00024)
Abstract ORCID License
0.00 0
26 Abaloparatida: el nuevo fármaco anabólico (10.20960/revosteoporosmetabminer.00030)
Abstract ORCID License
0.00 0
27 New forms of resistance to the action of human parathyroid h… (10.20960/revosteoporosmetabminer.00031)
Abstract ORCID License
0.00 0
28 Management of vitamin D deficiency in clinical practice: res… (10.20960/revosteoporosmetabminer.00034)
Abstract ORCID License
0.00 0
29 PTHrP-stimulated osteocytes stimulated prevent the different… (10.20960/revosteoporosmetabminer.00035)
Abstract ORCID License
0.00 0
30 Calcium-alkali syndrome: A rare cause of hypercalcemia? (10.20960/revosteoporosmetabminer.00037)
Abstract ORCID License
0.00 0
31 Limitations of immunodeficient mice as models for osteoporos… (10.20960/revosteoporosmetabminer.00041)
Abstract ORCID License
0.00 0
32 Osteonecrosis in the context of denosumab - Perspective of t… (10.20960/revosteoporosmetabminer.00042)
Abstract ORCID License
0.00 0
33 Challenges in the diagnosis and treatment of brown tumors: c… (10.20960/revosteoporosmetabminer.00043)
Abstract ORCID License
0.00 0
34 Dialogues between basic and clinical researchers: hypophosph… (10.20960/revosteoporosmetabminer.00046)
Abstract ORCID License
0.00 0
35 Bilateral osteonecrosis of the external auditory canal in a… (10.20960/revosteoporosmetabminer.00047)
Abstract ORCID License
0.00 0
36 Preferences of Spanish-speaking patients for communicating f… (10.20960/revosteoporosmetabminer.00048)
Abstract ORCID License
0.00 0
37 Musculoskeletal disorders and bisphosphonates: a disproporti… (10.20960/revosteoporosmetabminer.00050)
Abstract ORCID License
0.00 0
38 The regulation of phosphate and its association with alterat… (10.20960/revosteoporosmetabminer.00051)
Abstract ORCID License
0.00 0
39 The effect of falls on perceived health in the general popul… (10.20960/revosteoporosmetabminer.00055)
Abstract ORCID License
0.00 0
40 Exploring NF-κB silencing biosafety in mesenchymal stem cell… (10.20960/revosteoporosmetabminer.00056)
Abstract ORCID License
0.00 0
41 The most interesting papers on vitamin D in 2023 (10.20960/revosteoporosmetabminer.00057)
Abstract ORCID License
0.00 0
42 The activation of the purinergic system modulates the format… (10.20960/revosteoporosmetabminer.00058)
Abstract ORCID License
0.00 0
43 Effect of deficient vitamin D levels on muscular activity an… (10.20960/revosteoporosmetabminer.00060)
Abstract ORCID License
0.00 0
44 Proteomics applied to the study of vascular calcification in… (10.20960/revosteoporosmetabminer.00061)
Abstract ORCID License
0.00 0
45 Dialogues between basic and clinical researchers: hyperphosp… (10.20960/revosteoporosmetabminer.00062)
Abstract ORCID License
0.00 0
46 Study of bone turnover biomarkers behavior during the first… (10.20960/revosteoporosmetabminer.00063)
Abstract ORCID License
0.00 0
47 Identification in silico of miRNAs and their targets implica… (10.20960/revosteoporosmetabminer.00064)
Abstract ORCID License
0.00 0
48 Biogenesis of circular RNAs, biological functions and their… (10.20960/revosteoporosmetabminer.00065)
Abstract ORCID License
0.00 0
49 Circulating extracellular vesicles affect mesenchymal stroma… (10.20960/revosteoporosmetabminer.00066)
Abstract ORCID License
0.00 0
50 Impact of PTHrP on RAW 264.7 macrophage proliferation and po… (10.20960/revosteoporosmetabminer.00068)
Abstract ORCID License
0.00 0